Profusa, Inc. (PFSA) Income Statement

NASDAQ: PFSARevenue, profits, margins and EPS over 5 years.

PFSA 2025 at a glance

Fiscal year ended December 31, 2025 · U.S. dollars
Research & development+74.4%
$2.8M
2025 · hover or tap a bar for each year
2021: $7.7M2022: $4.2M (−45.2%)2023: $2.0M (−51.5%)2024: $1.6M (−21.0%)2025: $2.8M (+74.4%)
20212025
Operating expenses+193.8%
$13.2M
2025 · hover or tap a bar for each year
2021: $11.7M2022: $11.1M (−4.7%)2023: $6.1M (−45.5%)2024: $4.5M (−25.9%)2025: $13.2M (+193.8%)
20212025
Operating income
−$13.2M
2025 · hover or tap a bar for each year
2021: −$11.7M2022: −$11.1M2023: −$6.1M2024: −$4.5M2025: −$13.2M
20212025
Net income
−$35.8M
2025 · hover or tap a bar for each year
2021: −$10.3M2022: −$20.2M2023: −$10.3M2024: −$9.2M2025: −$35.8M
20212025
EPS (diluted)
−$696.93
2025 · hover or tap a bar for each year
2022: $2224.282023: $1033.95 (−53.5%)2024: −$11153.00 (−1,178.7%)2025: −$696.93
20212025

PFSA revenue and net income

RevenueNet incomeNet margin (right axis)

PFSA growth rates

to 2025
1 year3 years5 years10 years
Revenue————
Operating income————
Net income————
EPS (diluted)————

1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.

PFSA quarterly EPS vs estimates

Reported EPSAnalyst estimate

Profusa beat the analyst EPS estimate in 0 of the last 1 quarters. Next report: November 18, 2026.

PFSA income statement

Profusa, Inc. annual income statement
20252024202320222021
Revenue$0$0$0$0$0
Research & development$2.8M$1.6M$2.0M$4.2M$7.7M
Sales, general & admin$24.9M$3.0M$4.1M$5.2M$4.8M
Total operating expenses$13.2M$4.5M$6.1M$11.1M$11.7M
Operating income−$13.2M−$4.5M−$6.1M−$11.1M−$11.7M
Interest expense$5.1M$4.4M$4.3M$6.3M$4.1M
Income before taxes−$35.8M−$9.2M−$10.3M−$20.2M−$10.3M
Net income−$35.8M−$9.2M−$10.3M−$20.2M−$10.3M
EBITDA−$30.7M−$4.8M−$6.0M−$13.2M−$5.1M
EPS (diluted)−$696.93−$11153.00$1033.95$2224.28—

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in PFSA's financial statements (latest annual report filed December 31, 2025); data from EODHD. Sales, general & administrative expenses include sales and marketing.

PFSA financial results

Profusa reported no revenue in fiscal year 2025 (ended December 31, 2025). It had a net loss of $35.8 million. Diluted earnings per share came to −$696.93.

See the PFSA stock overview for the latest quote and news, or the PFSA chart for price history and technical indicators.

PFSA income statement FAQ

Does Profusa have revenue?

Profusa reported no revenue for fiscal year 2025, which ended on December 31, 2025.

Is Profusa profitable?

No. Profusa reported a net loss of $35.8 million in fiscal 2025.

How much does Profusa spend on research and development?

Profusa spent $2.8 million on research and development in fiscal 2025.

What are Profusa's earnings per share?

Profusa earned $-696.93 per diluted share in fiscal 2025, compared with $-11153.00 a year earlier.

When will Profusa report its next earnings?

Profusa is expected to report results for the quarter ending September 30, 2026 on November 18, 2026.

When does Profusa's fiscal year end?

Profusa's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on December 31, 2025.

Medical Devices income statements